(Q54444894)

29 May 2018

title

Treatment of severe nephrotic syndrome with meclofenamate: an uncontrolled pilot study. (English)

1 reference

29 May 2018

1 reference

J A Velosa

1 reference

29 May 2018

V E Torres

1 reference

29 May 2018

J V Donadio

1 reference

29 May 2018

R D Wagoner

1 reference

29 May 2018

K E Holley

1 reference

29 May 2018

K P Offord

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 September 1985

1 reference

29 May 2018

published in

Mayo Clin Proc

1 reference

29 May 2018

volume

1 reference

29 May 2018

issue

1 reference

29 May 2018

page(s)

586-592

1 reference

29 May 2018

Focal glomerulosclerosis--a progressive lesion associated with steroid-resistant nephrotic syndrome

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

Controlled trial of prednisone in adult patients with the nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

Treatment of the nephrotic syndrome with indomethacin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

Effect of indomethacin on glomerular permeability in the nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

Meclofenamate Treatment of Recurrent Idiopathic Nephrotic Syndrome With Focal Segmental Glomerulosclerosis After Renal Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

Pathogenesis of the glomerulopathy associated with renal infarction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

Focal glomerulosclerosis: natural history and treatment. A report of 70 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

Attenuation of furosemide's diuretic effect by indomethacin: Pharmacokinetic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

Nonsteroidal antiinflammatory drugs (second of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

The Effect of Indomethacin on Proteinuria and Kidney Function in the Nephrotic Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960980-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)60980-X

1 reference

29 May 2018

1 reference

29 May 2018